#ACC20 – [Abstract Only] Randomized Trial: Rivaroxaban in Peripheral Artery Disease after Revascularization
30 Mar, 2020 | 01:05h | UTCRivaroxaban in Peripheral Artery Disease after Revascularization – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: VOYAGER-PAD: Rivaroxaban Associated With Reduced Adverse Limb, CV Events in PAD Patients – American College of Cardiology (free) AND VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events – TCTMD (free)
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)